Swiss Life Sciences giant Lonza plans 1.4 lakh sq. ft. Global Capability Centre in Hyderabad
Switzerland-headquartered life sciences major Lonza Group AG is advancing plans to establish a Global Capability Centre (GCC) in Hyderabad, with reports indicating that the company has leased approximately 1.4 lakh square feet of office space at DivyaSree Techridge in Lanco Hills

The proposed facility, reportedly arranged through premium coworking operator The Executive Centre, is designed to accommodate around 2,000 seats. The development represents another significant addition to Hyderabad's expanding global capability centre ecosystem, particularly in the pharmaceutical, biotechnology and life sciences sectors.
Lonza, one of the world's leading contract development and manufacturing organisations (CDMOs), had formally announced its decision to establish a GCC in Hyderabad in March 2026. The company selected the city after evaluating multiple locations, citing its skilled workforce, infrastructure and established life sciences ecosystem.
The latest reports concerning the proposed office space suggest progress towards operationalising the centre. However, the reported lease details and seating capacity have not yet been independently confirmed through an official company announcement.
Founded in 1897, Lonza operates more than 30 development and manufacturing facilities across the world and employs nearly 20,000 professionals. The company reported sales of CHF 6.5 billion in 2025, reflecting its substantial presence in the global pharmaceutical manufacturing industry.
Lonza provides specialised services to pharmaceutical and biotechnology companies, supporting the development and manufacturing of medicines across areas such as biologics, small molecules, bioconjugates, and cell and gene therapies.
The Hyderabad GCC is expected to support the company's international operations through digital, scientific and operational functions. These could include data management, quality systems, regulatory support, technology services and coordination with its global manufacturing network.
The company's recruitment activity also indicates that preparations for the Hyderabad centre are progressing. A Lonza job advertisement for a senior quality leadership position refers to plans to build a team of more than 250 quality professionals and develop the centre into a 1,000-employee global hub. This is a staffing objective, distinct from the reported 2,000-seat capacity of the proposed office facility.
Earlier, a Lonza delegation met Telangana Industries and Commerce Minister D. Sridhar Babu and Telangana Lifesciences CEO Shakthi M. Nagappan to communicate the company's decision to establish its centre in Hyderabad.
Welcoming the investment, Sridhar Babu said the company's presence would strengthen Telangana's position in the global biopharmaceutical industry and create opportunities for high-value employment.
The development comes as Hyderabad increasingly attracts multinational companies seeking specialised talent in pharmaceuticals, biotechnology, research, digital technology and business operations. The emergence of life sciences GCCs is also broadening the city's reputation beyond its traditional strength in information technology services.
While Lonza's decision to establish a Hyderabad GCC is confirmed, the final investment amount, operational launch date and employment targets have not been formally disclosed. The reported 1.4 lakh-square-foot facility nevertheless signals the potential scale of the company's planned presence in the Telangana capital.